Paradigm Biocapital Advisors LP Sells in Q3 2024

Paradigm Biocapital Advisors LP

  • $2.77 Billion
  • Q3 2024
Stock Shares change Price Range Shares Held Trade History
OLMA
Olema Pharmaceuticals, Inc.

Healthcare
-2.4M
- 30.37%
$10.41 - $16.46 $25M - $39.5M
5.5M $65.7M
CMPS
Compass Pathways PLC

Healthcare
-1.18M
- 50.34%
N/A
1.16M $9.91M
KURA
Kura Oncology, Inc.

Healthcare
-208K
- 4.58%
$18.57 - $23.23 $3.86M - $4.83M
4.33M $84.6M
ARVN
Arvinas, Inc.

Healthcare
-98.2K
- 4.03%
$23.66 - $32.73 $2.32M - $3.21M
2.34M $57.6M
Disc Medicine Inc
-1.21M
- 44.63%
N/A
1.5M $0
VRDN
Viridian Therapeutics, Inc.\De

Healthcare
-660
- 0.02%
$12.16 - $23.33 $8.03K - $15.4K
2.9M $65.9M
ARGX
Argenx Se

Healthcare
-57.8K
- 10.73%
$434.22 - $551.9 $25.1M - $31.9M
480K $261M
Activity Summary
Buys All Purchases 22 New Holdings 7 Increased Positions 15 Sells All Sells 7 Reductions 7 Sold out 0 Options Calls 2 Puts 0
Track This Portfolio

Track Paradigm Biocapital Advisors LP Portfolio

Follow Paradigm Biocapital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Biocapital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Biocapital Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email